Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Protective interplay: Mycobacterium tuberculosis diminishes SARS-CoV-2 severity through innate immune priming

Frontiers in Immunology(2024)10.3389/fimmu.2024.1424374Source: DataRank Database

Protective interplay: Mycobacterium tuberculosis diminishes SARS-CoV-2 severity through innate immune priming is a research paper published in Frontiers in Immunology (2024). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)OA: goldTopics (39)IDs (PubMed, PMC)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Debora Ferede,Hazem F. M. Abdelaal ORCID,Bryan J. Berube ORCID,Brendan K. Podell ORCID,Sasha E. Larsen ORCID

Live enrichment

PubMed:38966641 PMC:PMC11222399

NIAID NIH HHS

Grant: T32 AI007509

National Institutes of Health

Grant: 5R01AI125160-04

Immunotherapy to prevent drug-resistant tuberculosis

National Institutes of Health

Grant: 1P30AI168034-01

Seattle Tuberculosis Research Advancement Center

goldLicense: cc-by

publisherhttps://doi.org/10.3389/fimmu.2024.1424374

publisherhttps://www.frontiersin.org/articles/10.3389/fimmu.2024.1424374/full

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11222399/pdf/fimmu-15-1424374.pdf

Europe_PMChttps://europepmc.org/articles/PMC11222399

Europe_PMChttps://europepmc.org/articles/PMC11222399?pdf=render

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

LungAnimalsMice, Inbred C57BLHumansMiceMycobacterium tuberculosisTuberculosisDisease Models, AnimalCytokinesSeverity of Illness IndexVirus ReplicationFemaleImmunity, InnateCoinfectionCOVID-19SARS-CoV-2

Keywords

Mycobacterium tuberculosisTuberculosisCo-infectionCovid-19Sars-cov-2CoinfectionImmunologyRC581-607Virus ReplicationSeverity of Illness IndexImmunity, InnateMice, Inbred C57BLMiceDisease Models, AnimalAnimalsHumansCytokinesFemaleImmunologic diseases. AllergyLung

Sustainable Development Goals

SDG 3: 3. Good health